Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs

RSC Advances Pub Date: 2022-10-31 DOI: 10.1039/D2RA05370E

Abstract

FDA-approved antiviral agents represent an important class that has attracted attention in recent years to combat current and future threats of viral pandemics. Fluorine ameliorates the electronic, lipophilic and steric problems of drugs. Additionally, fluorine can prolong drug activity and improve metabolic stability, thereby, modifying their pharmacodynamic and pharmacokinetic character. Herein, we summarized the fluorinated FDA-approved antiviral agents, dealing with biological aspects, mechanisms of action, and synthetic pathways.

Graphical abstract: Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs
Recommended Literature